Detalles de la búsqueda
1.
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years.
N Engl J Med
; 388(3): 214-227, 2023 01 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36652353
2.
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.
Nature
; 586(7830): 594-599, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32998157
3.
Identification of a Novel Keto Sugar Component in Streptococcus pneumoniae Serotype 12F Capsular Polysaccharide and Impact on Vaccine Immunogenicity.
J Immunol
; 210(6): 764-773, 2023 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36723033
4.
Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years.
Clin Infect Dis
; 75(3): 390-398, 2022 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34940806
5.
Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.
Nature
; 590(7844): E17, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33469214
6.
Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age.
Clin Infect Dis
; 73(7): e1489-e1497, 2021 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32716500
7.
A Novel Hexavalent Capsular Polysaccharide Conjugate Vaccine (GBS6) for the Prevention of Neonatal Group B Streptococcal Infections by Maternal Immunization.
J Infect Dis
; 220(1): 105-115, 2019 06 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30778554
8.
A Phase Three Study of the Safety and Immunogenicity of a Four-dose Series of 20-Valent Pneumococcal Conjugate Vaccine in Healthy Infants.
Pediatr Infect Dis J
; 43(6): 596-603, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38535409
9.
A Phase 3, Single-arm Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine in Healthy Children 15 Months Through <18 Years of Age.
Pediatr Infect Dis J
; 43(6): 574-581, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38502894
10.
A phase 3 randomized trial of the safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in adultsâ¯≥â¯60 years of age in Japan, South Korea, and Taiwan.
Vaccine
; 42(5): 1071-1077, 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38267330
11.
Staphylococcus aureus manganese transport protein C is a highly conserved cell surface protein that elicits protective immunity against S. aureus and Staphylococcus epidermidis.
J Infect Dis
; 205(11): 1688-96, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22474033
12.
A Longitudinal Study of Group A Streptococcal Colonization and Pharyngitis in US Children.
Pediatr Infect Dis J
; 42(12): 1045-1050, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37768176
13.
Comparison of pneumococcal immunogenicity elicited by the PCV13 and PCV15 vaccines in adults 18 through 49 years of age.
Vaccine
; 41(45): 6625-6629, 2023 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37793976
14.
2022 White Paper on Recent Issues in Bioanalysis: Enzyme Assay Validation, BAV for Primary End Points, Vaccine Functional Assays, Cytometry in Tissue, LBA in Rare Matrices, Complex NAb Assays, Spectral Cytometry, Endogenous Analytes, Extracellular Vesicles Part 2 - Recommendations on Biomarkers/CDx, Flow Cytometry, Ligand-Binding Assays Development & Validation; Emerging Technologies; Critical Reagents Deep Characterization.
Bioanalysis
; 15(15): 861-903, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37584363
15.
Streptococcus pneumoniae serotype 15B polysaccharide conjugate elicits a cross-functional immune response against serotype 15C but not 15A.
Vaccine
; 40(33): 4872-4880, 2022 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35810060
16.
A randomized phase 1 study of the safety and immunogenicity of 2 novel pneumococcal conjugate vaccines in healthy Japanese adults in the United States.
Hum Vaccin Immunother
; 17(7): 2249-2256, 2021 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33545022
17.
Performance of a Four-Antigen Staphylococcus aureus Vaccine in Preclinical Models of Invasive S. aureus Disease.
Microorganisms
; 9(1)2021 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33467609
18.
A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age.
Vaccine
; 39(38): 5428-5435, 2021 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34315611
19.
A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination.
Vaccine
; 39(51): 7494-7502, 2021 12 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34839993
20.
A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults.
Nat Commun
; 12(1): 7105, 2021 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34907170